Stay updated on Gilead Sciences Press Releases
Sign up to get notified when there's something new on the Gilead Sciences Press Releases page.

Latest updates to the Gilead Sciences Press Releases page
- Check4 days agoChange DetectedNew items added to the News Releases list for November 7, 2025 (ASCENT-07 update and Livdelzi PBC efficacy) and November 4, 2025 (investor conferences). Older October 2025 items were removed from the first-page listing.SummaryDifference4%

- Check11 days agoChange DetectedThree new press releases were added to the News Releases page (Nov 3, 2025; Oct 31, 2025; Oct 30, 2025) covering ASH 2025 data, an award, and quarterly results. Older items (Oct 9, 2025; Sep 25, 2025; Sep 4, 2025) were removed.SummaryDifference5%

- Check18 days agoChange DetectedA new press release entry about Livdelzi® (Seladelpar) for PBC and Bulevirtide is added to the News Releases page, and an older entry about the 'Choose U' campaign is removed.SummaryDifference4%

- Check26 days agoChange DetectedUpdate: Old items from August/September 2025 are removed and newer October 2025 press releases and conference data are added, signaling a fresh wave of timely medical news coverage.SummaryDifference89%

- Check33 days agoChange DetectedUpdates the press release from Q2 2025 results to Q3 2025 results with the new communication date and earnings release date.SummaryDifference75%

- Check47 days agoChange DetectedThe page now highlights a STEM education grant from the Gilead Foundation, replacing a prior regulatory update about Lenacapavir. The focus has shifted from regulatory news to philanthropy, with dates updated to September 25, 2025 and July 25, 2025 respectively.SummaryDifference74%

Stay in the know with updates to Gilead Sciences Press Releases
Enter your email address, and we'll notify you when there's something new on the Gilead Sciences Press Releases page.